Radiotherapy of germinomas involving the basal ganglia and thalamus.
Nine patients with histologically confirmed germinomas of the basal ganglia and thalamus (GBT) were treated by radiotherapy. The average dose of 52.5 Gy was delivered to the tumor bed, 37 Gy to the whole brain and 24.8 Gy to the CNS axis. The local control, which was verified by CT scan, was achieved in all patients. All patients are alive 11 to 96 months after radiotherapy. As with other intracranial germinomas, geminomas of the basal ganglia and thalamus respond well to radiotherapy and the prognosis is good after treatment.
Huh
S J
SJ
Department of Therapeutic Radiology, Soonchunhyang University Hospital, Seoul, Republic of Korea.
Kim
I H
IH
Ha
S W
SW
Park
C I
CI
D000293:Adolescent; D000328:Adult; D001479:Basal Ganglia / Q000000981:diagnostic imaging; D001932:Brain Neoplasms / Q000000981:diagnostic imaging / Q000532:radiotherapy*; D002648:Child; D004407:Dysgerminoma / Q000000981:diagnostic imaging / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011879:Radiotherapy Dosage; D013788:Thalamus / Q000000981:diagnostic imaging; D014057:Tomography, X-Ray Computed